ACDM News Item

Regulatory Considerations DMEG reviews recent MHRA regulatory updates

Date: April 22, 2026

The ACDM Regulatory considerations DMEG Regulatory considerations reviewed several recent publications from the UK Medicines and Healthcare products Regulatory Agency (MHRA) including the release of new guidelines, updates to the Inspection Dossier templates and annotations to ICH E6 (R3) and ICH E8 (R1). These guidelines go into effect on April 28, 2026.

To assist data managers in complying with the new guidelines, the DMEG is releasing a summary of the highlights which impact data managers including:

o AI/ML documentation for Data Management
o Clinical trial record archiving and retention
o Data protection and subject rights

View the paper here
The Regulatory Considerations DMEG will continue to review MHRA guidance as they are published, and an upcoming review will be on the Guidance on quality and risk proportionality (published 27 March 2026). In the interim, you can access that document at the MHRA Clinical Trial Hub: https://www.gov.uk/guidance/clinical-trials-for-medicines-guidance-on-quality-and-risk-proportionality

Explore More News

Regulatory Considerations DMEG Update – September 2024

The Regulatory Considerations DMEG are waiting for the release of ICH GCP E6 (R3) Annex 1 . . .

Digital Data Flow (DDF) integration through the lens of electronic Patient-Reported Outcomes (ePRO)

This article has been submitted by Leeni Joshua of ICON plc Introduction: Digital Data . . .

Guidance for Industry: Conducting Clinical Trials With Decentralized Elements

The Conducting Clinical Trials With Decentralized Elements final guidance has now been . . .

Welcome FGK Clinical Research as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome FGK Clinical . . .

Welcome LINK Medical as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome LINK Medical as . . .

Welcome Zilla Clinicals as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Zilla Clinicals . . .

Challenge ChatGPT: CDMs vs AI

Following a recent Hot Topic discussion that explained how machine learning models are . . .

Welcome Boehringer Ingelheim as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Boehringer . . .

Welcome Datacapt as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Datacapt as a . . .

Welcome Climedo as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Climedo as a . . .

Clinical Trials for Medicines – New Notification Scheme

The MHRA have recently launched a new notification scheme, the first step in their . . .

EMA Management Board: Highlights of October 2023 meeting

The EMA’s Management Board met on 5 October in Amsterdam. The article below covers the . . .